Dr Carbone is an Associate Professor at the University of Milano-Bicocca and Honorary Consultant Hepatologist at the European Reference Network-Liver Centre San Gerardo University Hospital, Monza where he is the clinical lead of the cholestatic liver disease programme.
He qualified in Medicine in Rome, Italy and trained in Hepatology in Italy and in the UK.
His research interest mainly relates to study disease mechanisms in cholestatic liver diseases. He runs a research programme in cholestatic and autoimmune liver diseases that encompasses joint modelling of molecular, biochemical and radiological data, and their conversion into meaningful outputs that can inform mechanistic understanding, health care decisions, and the design of innovative clinical trials. He is a steering committee member of the Global PBC study group, board member of the PBC Foundation and Council member of the Global Liver Institute. He is in the panel of the national guidelines for PBC and PSC and sit on the special interest group of the Italian Association of the Study of the Liver (AISF) for application of artificial intelligence in liver disease. In 2020 he received the “Young Investigator Lecture” award from the AISF and in 2021 he received “Rising Star” award from the United European Gastroenterology (UEG). He is Associate Editor of Digestive and Liver Disease, sit in the editorial board of Hepatology, and co-authored 108 scientific articles (h-index 27).
Carbone, M., Mells, G., Pells, G., Dawwas, M., Newton, J., Heneghan, M., et al. (2013). Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid. GASTROENTEROLOGY, 144(3), 560-569 [10.1053/j.gastro.2012.12.005]. Detail
Carbone, M., Nardi, A., Flack, S., Carpino, G., Varvaropoulou, N., Gavrila, C., et al. (2018). Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score. THE LANCET. GASTROENTEROLOGY & HEPATOLOGY, 3(9), 626-634 [10.1016/S2468-1253(18)30163-8]. Detail
Carbone, M., Mells, G., Alexander, G., Westbrook, R., Heneghan, M., Sandford, R., et al. (2013). Calcineurin inhibitors and the IL12A locus influence risk of recurrent primary biliary cirrhosis after liver transplantation. AMERICAN JOURNAL OF TRANSPLANTATION, 13(4), 1110-1111 [10.1111/ajt.12132]. Detail
Carbone, M., & Neuberger, J. (2014). Autoimmune liver disease, autoimmunity and liver transplantation. JOURNAL OF HEPATOLOGY, 60(1), 210-223 [10.1016/j.jhep.2013.09.020]. Detail
Carbone, M., Sharp, S., Flack, S., Paximadas, D., Spiess, K., Adgey, C., et al. (2016). The UK-PBC risk scores: Derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis. HEPATOLOGY, 63(3), 930-950 [10.1002/hep.28017]. Detail
Research and teaching assignments
- Ricercatore universitario a t.d. - Università degli Studi di MILANO-BICOCCA, 2016 - 2019
- Ricercatore universitario a t.d. - Università degli Studi di MILANO-BICOCCA, 2019 - 2022